Cancer genome profiling for GI cancers

In Japan, cancer genome profiling (CGP) for cancer patients without standard treatment has been covered by public insurance since June 2019. This study analyzed data of 122 patients with gastrointestinal tumors who underwent CGP to clarify cancer genome medicine’s current status and possible problems at the Tokushima University Hospital. The major types of cancer included pancreatic (n = 30), colorectal (n = 25), biliary tract (n = 15), gastric (n = 11), and hepatocellular carcinoma (n = 8). CGP tests included F1CDx in 70 patients (57%), F1LCDx in 36 (30%), TSO500 in 14 (11%), and NCC Oncopanel in 2 (2%). Actionable gene alterations were identified in 72 patients (59%), but only 5 patients (4%) were treated for pancreatic (n = 1), colorectal (n = 3), and small bowel cancers (n = 1). The main reasons for not receiving genotype-matched therapy included the lack of appropriate drugs or clinical trials that matched the actionable gene alterations (n = 40) and the inability to participate in clinical trials (n = 10). There is still not a sufficient number of patients receiving genotype-matched treatment for gastrointestinal cancers. To promote cancer genome medicine in regional areas, attempts to improve access to genotype-matched therapies are required, as well as to promote the development of new molecular-targeted drugs and clinical trials for these drugs

肝細胞癌においてmiR125b-5pはAtaxin1による上皮間葉転換を介してソラフェニブ耐性を示す

The mechanism of resistance to sorafenib in hepatocellular carcinoma (HCC) remains unclear. We analyzed miRNA expression profiles in sorafenib-resistant HCC cell lines (PLC/PRF5-R1/R2) and parental cell lines (PLC/PRF5) to identify the miRNAs responsible for resistance. Drug sensitivity, migration/invasion capabilities, and epithelial-mesenchymal transition (EMT) properties were analyzed by biochemical methods. The clinical relevance of the target genes to survival in HCC patients were assessed using a public database. Four miRNAs were significantly upregulated in PLC/PRF5-R1/-R2 compared with PLC/PRF5. Among them, miR-125b-5p mimic-transfected PLC/PRF5 cells (PLC/PRF5-miR125b) and showed a significantly higher IC50 for sorafenib compared with controls, while the other miRNA mimics did not. PLC/PRF5-miR125b showed lower E-cadherin and higher Snail and vimentin expression—findings similar to those for PLC/PRF5-R2—which suggests the induction of EMT in those cells. PLC/PRF5-miR125b exhibited significantly higher migration and invasion capabilities and induced sorafenib resistance in an in vivo mouse model. Bioinformatic analysis revealed ataxin-1 as a target gene of miR-125b-5p. PLC/PRF5 cells transfected with ataxin-1 siRNA showed a significantly higher IC50, higher migration/invasion capability, higher cancer stem cell population, and an EMT phenotype. Median overall survival in the low-ataxin-1 patient group was significantly shorter than in the high-ataxin-1 group. In conclusion, miR-125b-5p suppressed ataxin-1 and consequently induced Snail-mediated EMT and stemness, leading to a poor prognosis in HCC patients.The mechanism of resistance to multikinase inhibitors in hepatocellular carcinoma (HCC) remains unclear. We analyzed miRNA expression profiles in sorafenib-resistant HCC cell lines (PLC/PRF5-R1/R2) and parental cell lines (PLC/PRF5) to identify the responsible miRNAs and target genes involved in the mechanism of resistance. Four miRNAs were significantly upregulated. Among them, we found that miR-125-5p induced sorafenib resistance in HCC cells and in a mouse model. We also revealed that miR-125-5p suppressed ataxin-1 as a target gene and consequently induced Snail-mediated epithelial-mesenchymal transition (EMT) and cancer stemness. Moreover, we demonstrated that ataxin-1 expression has an impact on the prognosis of patients with HCCs. In the future, by comparing the expression status of miR-125b-5p/ataxin-1 and the effect of sorafenib in the clinical setting, it is expected that miR-125b-5p will be established as an effective drug selection marker for treatment selection in patients with HCC

Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females

The clinical difference between nonalcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver disease (MAFLD) between the two sexes is unclear. This study aimed to determine the influences of alcohol consumption and qualitative abdominal fat between male and female patients with NAFLD and MAFLD. This cross-sectional study examined 11,766 participants who underwent health check-ups comparing lifestyle habits, biochemical features, and noninvasive liver fibrosis scores, between non-MAFLD and MAFLD groups. Furthermore, differences in alcohol consumption and qualitative abdominal fat were examined between male and female patients with NAFLD and MAFLD. The prevalence of metabolic dysregulation, ratio of visceral fat area to subcutaneous fat area, and noninvasive liver fibrosis scores were significantly higher in male patients with MAFLD than in those with NAFLD (p  70 g/week, several noninvasive liver fibrosis scores were significantly higher in the MAFLD group than in the NAFLD group (all p < 0.05). The influences of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD were different between sexes. The development of liver fibrosis should be considered in male patients with MAFLD who exceed mild drinking

Sustained proliferation in cancer: mechanisms and novel therapeutic targets

Proliferation is an important part of cancer development and progression. This is manifest by altered expression and/or activity of cell cycle related proteins. Constitutive activation of many signal transduction pathways also stimulates cell growth. Early steps in tumor development are associated with a fibrogenic response and the development of a hypoxic environment which favors the survival and proliferation of cancer stem cells. Part of the survival strategy of cancer stem cells may manifested by alterations in cell metabolism. Once tumors appear, growth and metastasis may be supported by overproduction of appropriate hormones (in hormonally dependent cancers), by promoting angiogenesis, by undergoing epithelial to mesenchymal transition, by triggering autophagy, and by taking cues from surrounding stromal cells. A number of natural compounds (e.g., curcumin, resveratrol, indole-3-carbinol, brassinin, sulforaphane, epigallocatechin-3-gallate, genistein, ellagitannins, lycopene and quercetin) have been found to inhibit one or more pathways that contribute to proliferation (e.g., hypoxia inducible factor 1, nuclear factor kappa B, phosphoinositide 3 kinase/Akt, insulin-like growth factor receptor 1, Wnt, cell cycle associated proteins, as well as androgen and estrogen receptor signaling). These data, in combination with bioinformatics analyses, will be very important for identifying signaling pathways and molecular targets that may provide early diagnostic markers and/or critical targets for the development of new drugs or drug combinations that block tumor formation and progression

Mesodermal fate decisions of a stem cell: the Wnt switch

Stem cells are a powerful resource for cell-based transplantation therapies in osteodegenerative disorders, but before some kinds of stem cells can be applied clinically, several aspects of their expansion and differentiation need to be better controlled. Wnt molecules and members of the Wnt signaling cascade have been ascribed a role in both these processes in vitro as well as normal development in vivo. However some results are controversial. In this review we will present the hypothesis that both canonical and non-canonical signaling are involved in mesenchymal cell fate regulation, such as adipogenesis, chondrogenesis and osteogenesis, and that in vitro it is a timely switch between the two that specifies the identity of the differentiating cell. We will specifically focus on the in vitro differentiation of adipocytes, chondrocytes and osteoblasts contrasting embryonic and mesenchymal stem cells as well as the role of Wnts in mesenchymal fate specification during embryogenesis

Elastically constrained phase-separation dynamics competing with the charge process in the LiFePO4/FePO4 system

By using phase-field computer simulations, we have investigated the effects of the coherent strain due to the phase separation in the olivine-type LiFePO[4]. In this system, the coherent elastic-strain energy due to the lattice mismatch between LiFePO[4] and FePO[4] phases accompanied by insertion and extraction of Li ions is considered to play a crucial role in the phase separation kinetics during the charge/discharge process. The present phase-field micromechanics simulations reveal several significant features of the LiFePO[4]/FePO[4] system accompanying the coherent strain, such as the retardation of the phase separation, the charge rate dependence, the thermodynamic stability of coherent interfaces between dual phases, etc. Nucleation of the new phase is found to be fundamentally unlikely in terms of the elastic strain energy, except in the vicinity of the surface of the particles, and thus the phase separation would be dominated by the spinodal decomposition process. When the nucleus is present precedently, however, the phase separation can proceed in the mixture mode of the domino cascade and spinodal decomposition processes

Anatomic dependency of phase shifts in the cerebral venous system of neonates at susceptibility-weighted magnetic resonance imaging

PURPOSE: To assess the anatomic variation and age-related changes of phase shifts in the neonatal cerebral venous system at susceptibility-weighted imaging (SWI).MATERIALS AND METHODS: Thirty-five neonates who had undergone SWI and who did not have any intracranial or systemic abnormalities were retrospectively assessed. Phase shifts in the veins in the deep gray matter and in the cortical veins in the frontal, rolandic, and parietal areas were measured and compared. Correlations between phase ratio (ratio of the phase shift in the vein in the deep gray matter to that in the cortical veins) and gestational age at birth, gestational age at magnetic resonance imaging (MRI), and age after birth were assessed.RESULTS: Phase shift in the veins in the deep gray matter was significantly higher than those in the cortical veins (P < 0.01). Among the cortical veins, the venous phase shift in the rolandic area was significantly higher than those in the frontal and parietal areas (P < 0.01). There was a negative correlation between the phase ratio and the gestational age at MRI (Spearman p = -0.35, P = 0.04).CONCLUSION: An anatomical variation in phase shifts was identified in the neonatal venous system. The observed reduction in phase shift differences between the veins in the deep gray matter and those in the cortex as gestational age at MRI increased may reflect brain development. J. Magn. Reson. Imaging 2011;. &copy; 2011 Wiley Periodicals, Inc

What determines the critical size for phase separation in LiFePO4 in lithium ion batteries?

LiFePO4 characteristically shows a plateau voltage due to a two-phase (LiFePO4/FePO4) separation during the charge/discharge process in Li ion batteries. In this study, we clearly show that monodispersed nano-sized (about 10 nm) LiFePO4 particles exhibit a complete single-phase reaction without showing any plateau voltage. Since the elastic strain due to lattice mismatch between LiFePO4 and FePO4 would be easily released near the surface, elastic effects are usually expected to weaken, but, in contrast to this expectation, phase separation does not occur experimentally in such small nanoparticles. Consideration on the basis of only static thermodynamics is insufficient to explain why such a single-phase reaction occurs in nano-sized particles. In contrast, the mechanism of the single-phase reaction can be naturally understood, when we consider a kinetics concept based on the preferred wavelength for stable growth of the spinodal wave under such an elastic constraint